Seif Al Abri1, Akiko Kowada2, Fatma Yaqoubi3, Sulien Al Khalili3, Nduku Ndunda4, Eskild Petersen5. 1. Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman. Electronic address: salabri@gmail.com. 2. General Affairs Department, Ota City Office, Tokyo, Japan. 3. Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman. 4. Medical Affairs, Qiagen GmbH, Dubai, United Arab Emirates. 5. Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark.
Abstract
OBJECTIVE: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman. METHODS: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment. RESULTS: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved. CONCLUSIONS: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.
OBJECTIVE: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman. METHODS: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment. RESULTS: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved. CONCLUSIONS: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.
Authors: Mouaddh Abdulmalik Nagi; Mustafa Ali Ali Rezq; Sermsiri Sangroongruangsri; Montarat Thavorncharoensap; Pramitha Esha Nirmala Dewi Journal: Glob Health Res Policy Date: 2022-07-25
Authors: Sara Al Mahrouqi; Amal Gadalla; Saleh Al Azri; Salama Al-Hamidhi; Amina Al-Jardani; Abdullah Balkhair; Amira Al-Fahdi; Laila Al Balushi; Samiya Al Zadjali; Asmahan Mohammed Nasser Al Marhoubi; Hamza A Babiker Journal: PeerJ Date: 2022-07-28 Impact factor: 3.061